TimothyRMorganMD
Gastroenterology • Long Beach, CAProfessor, Medicine, University of California, Irvine College of Medicine
Dr. Morgan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5901 E 7th St
VA Long Beach Healthcare System - 11
Long Beach, CA 90822Phone+1 562-826-5756Fax+1 562-826-5436
Education & Training
LAC-USC Medical CenterFellowship, Hepatology, 1985 - 1986
University of Arizona College of Medicine-TucsonFellowship, Gastroenterology, 1983 - 1985- LAC-USC Medical CenterFellowship, Hepatology, 1982 - 1983
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1978 - 1982
Emory University School of MedicineClass of 1978
Certifications & Licensure
CA State Medical License 1979 - 2027
AZ State Medical License 1985 - 1987
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellow (FAASLD) American Association for the Study of Liver Diseases, 2010
- Fellow (FACP) American College of Physicians, 2005
- Fellow (AGAF) American Gastroenterological Association, 2009
Clinical Trials
- Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma Start of enrollment: 2008 Jul 01
- Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1 Start of enrollment: 2013 Aug 01
- A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis Start of enrollment: 2014 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Reply: AASLD Resmetirom Guidance.Vincent L Chen, Timothy R Morgan, Yaron Rotman, Heather M Patton, Kenneth Cusi
Hepatology. 2025-02-14 - Reply: Polygenic risk score in cirrhosis: Does the etiology matter?Tae-Hwi Schwantes-An, Timothy R Morgan, Devanshi Seth
Hepatology Communications. 2025-02-01 - A machine-learning model score predicts advanced fibrosis and cirrhosis in indeterminate FIB-4 patients.Sebastian Niezen, Timothy R Morgan, Heather M Patton, Jasmohan S Bajaj, Elliot B Tapper
Clinical Gastroenterology and Hepatology. 2025-01-30
Journal Articles
- The Veterans Affairs Hepatitis C Treatment ConsiderationsTimothy Morgan, MD, Nature
Press Mentions
American Liver Foundation and the United States Department of Veterans Affairs and Veteran Health Administration Partner to Help Veterans at Risk or Living with Liver DiseaseJanuary 23rd, 2025- Prolonged Alcohol Use and Its Detrimental Effects on Blood Protein SnapshotFebruary 10th, 2023
Pharmacists Could Play Bigger Role in Working with HCV PatientsFebruary 22nd, 2018
Grant Support
- Genetic Risk Factors For Alcoholic Cirrhosis - Genome-Wide Case-Control StudyNational Institute On Alcohol Abuse And Alcoholism2011
- Clinical Trial: HALT-CNational Center For Research Resources2008–2010
- Core--BiostatisticsNational Institute On Aging1991–1996
Professional Memberships
- Fellow
- Fellow
- American Association for the Study of Liver DiseasesFellow
- European Association for the Study of the LiverMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
